Evidence map›Paper›PMID 28613156›Full record

ArticleeLife2017

Reciprocal regulation of ARPP-16 by PKA and MAST3 kinases provides a cAMP-regulated switch in protein phosphatase 2A inhibition.

Veronica Musante, Lu Li, Jean Kanyo, Tukiet T Lam, Christopher M Colangelo, Shuk Kei Cheng, A Harrison Brody, Paul Greengard, Nicolas Le Novère, Angus C Nairn

Open access · goldAbstract read
In one paragraph

Article in eLife, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Signal pathways and precision therapy of small-cell lung cancer.Signal transduction and targeted therapy · 2022
    Review
  8. Renal ATCirculation research · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. cAMP regulation of protein phosphatases PP1 and PP2A in brain.Biochimica et biophysica acta. Molecular cell research · 2019
    Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Veronica MusanteDepartment of Psychiatry, Yale University School of Medicine, New Haven, United States.ORCID 0000-0001-5244-9158
Lu LiThe Babraham Institute, Cambridge, United Kingdom.ORCID 0000-0002-6199-522X
Jean KanyoW.M. Keck Biotechnology Resource Laboratory, Yale University School Medicine, New Haven, United states.
Tukiet T LamW.M. Keck Biotechnology Resource Laboratory, Yale University School Medicine, New Haven, United states.
Christopher M ColangeloW.M. Keck Biotechnology Resource Laboratory, Yale University School Medicine, New Haven, United states.
Shuk Kei ChengLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, United States.
A Harrison BrodyLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, United States.
Paul GreengardLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, United States.
Nicolas Le NovèreThe Babraham Institute, Cambridge, United Kingdom.ORCID 0000-0002-6309-7327
Angus C NairnDepartment of Psychiatry, Yale University School of Medicine, New Haven, United States.ORCID 0000-0002-7075-0195
Rockefeller University · USW. M. Keck Foundation · USBabraham Institute · GBYale University · US

Funding

Yale/NIDA Neuroproteomics Research CenterP30DA018343 · NIDA · YALE UNIVERSITY · PI ANGUS C. NAIRN, Kenneth Robert WILLIAMS · 2004 to 2026
$37.1M
THE ROLE OF DARPPS IN THE ACUTE AND CHRONIC EFFECTS OF COCAINE AND AMPHETAMINEP01DA010044 · NIDA · ROCKEFELLER UNIVERSITY · PI GREENGARD, PAUL · 1996 to 2015
$23.6M
Yale Alzheimer Disease Research CenterP50AG047270 · NIA · YALE UNIVERSITY · PI MAROTTOLI, RICHARD · 2015 to 2019
$8.3M
Supplement for "Serine/Threonine Phosphatases in Neurological Diseases"R01NS091336 · NINDS · UNIVERSITY OF ARIZONA · PI PAGE, REBECCA, PETI, WOLFGANG · 2015 to 2019
$1.8M
Biotechnology and Biological Sciences Research Council BBS/E/B/000C0419NIA NIH HHS P50 AG047270NIDA NIH HHS P01 DA010044NIDA NIH HHS P30 DA018343NINDS NIH HHS R01 NS091336
6 · The paper itself

Abstract

ARPP-16, ARPP-19, and ENSA are inhibitors of protein phosphatase PP2A. ARPP-19 and ENSA phosphorylated by Greatwall kinase inhibit PP2A during mitosis. ARPP-16 is expressed in striatal neurons where basal phosphorylation by MAST3 kinase inhibits PP2A and regulates key components of striatal signaling. The ARPP-16/19 proteins were discovered as substrates for PKA, but the function of PKA phosphorylation is unknown. We find that phosphorylation by PKA or MAST3 mutually suppresses the ability of the other kinase to act on ARPP-16. Phosphorylation by PKA also acts to prevent inhibition of PP2A by ARPP-16 phosphorylated by MAST3. Moreover, PKA phosphorylates MAST3 at multiple sites resulting in its inhibition. Mathematical modeling highlights the role of these three regulatory interactions to create a switch-like response to cAMP. Together, the results suggest a complex antagonistic interplay between the control of ARPP-16 by MAST3 and PKA that creates a mechanism whereby cAMP mediates PP2A disinhibition.

Indexed as

Gene Expression RegulationCyclic AMPCyclic AMP-Dependent Protein KinasesHEK293 CellsHumansMicrotubule-Associated ProteinsPhosphoproteinsProtein Phosphatase 2Protein Serine-Threonine KinasesCyclic AMPCyclic AMP-Dependent Protein Kinasescyclic AMP-regulated phosphoprotein 16MAST3 protein, humanMicrotubule-Associated ProteinsPhosphoproteinsProtein Phosphatase 2Protein Serine-Threonine Kinasescomputational biologycomputational modelhek293 cell lineneuronsneurosciencephosphatase PP2Apurified proteinssystems biology

Identifiers

PMID28613156
PMCPMC5515580
OpenAlexW2626382019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.